Login
Companies $DERM
$3.80 +$0.10 (2.7%) After hours
Journey Medical Corp logo

Journey Medical Corp

Compare classes
journeymedicalcorp.com

What Do They Do?

Sells and markets FDA-approved prescription medicines for skin conditions through specialty pharmacies, wholesalers and distributors.

How Do They Make Money?

Journey sells prescription products to specialty pharmacies, wholesalers and distributors, with product sales tied to delivery when customers receive the goods. It also earns revenue from supplying Amzeeq to Cutia and royalties on Cutia’s Amzeeq sales in China.

revenue
SegmentShareRevenue
Emrosi
Sold outright

24%
Qbrexza
Sold outright

41%
Accutane
Sold outright

21%
Foam franchise products (Amzeeq & Zilxi)
Sold outright

9.6%
Other / legacy
Sold outright
4.5%

Who Are Their Customers?

Journey sells primarily to specialty pharmacies, independent wholesalers and distributors, including through traditional national wholesalers. Wholesalers and distributors supply retail drug chains, independent pharmacies and managed-care organizations.

Do Revenues Turn Into Profits?

No. It lost $11.4M in FY2025.

Operating income, FY2025
−13% of revenue
▲ +40% (Loss) vs FY2024 (−$13.7M, −24%)
Net income, FY2025
−18% of revenue
▲ +22% (Loss) vs FY2024 (−$14.7M, −26%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +8%
vs $17.6M in Q3 FY2025
Net income
▲ +43% (Loss)
vs −$2.3M in Q3 FY2025
Qbrexza share of product revenue, net vs 43.2% in Q3 FY2025
  • Apr 21, 2026 Emrosi expands payer coverage after a third major GPO contract Payer access expanded from approximately 100 million to over 150 million commercial lives as of April 1, 2026.

Flat. Revenue was $61.9M in FY2025, about the same as the $63.1M of FY2021.

From clinical testing to marketed treatment The older report described a rosacea treatment in clinical testing; the latest says it was approved as Emrosi and that U.S. sales promotion began.

Revenue over time
Emrosi Qbrexza Accutane Foam franchise products (Amzeeq & Zilxi) Other / legacy Ximino Other branded products Exelderm Qbrexa Targadox Zilxi Amzeeq
$100M$50M$0

Who Do They Compete With?

Competes with Galderma

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support